Safety and Immunogenicity of COVID-19 Vaccination in Patients With Cancer
Clinical trial NCT05018078 · UNKNOWN
Trial details
- NCT number
- NCT05018078
- Sponsor
- Beijing 302 Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2023-08-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.